Crossmark

A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures

Crossref DOI link: https://doi.org/10.1038/s41386-018-0039-3

Published Online: 2018-02-27

Published Print: 2018-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Politte, Laura C.

Scahill, Lawrence

Figueroa, Janet

McCracken, James T.

King, Bryan

McDougle, Christopher J.
License Information

Text and Data Mining valid from 2018-02-27
More Information

Article History

Received: 29 September 2017

Revised: 8 December 2017

Accepted: 14 February 2018

First Online: 27 February 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below